← All Iradimed CORP filings

Iradimed CORP Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
IRMD
Iradimed CORP
SCHEDULE: Iradimed Insider Ownership Update: Susi Family Holdings
Roger E. Susi and associated family trusts report a combined 34.8% beneficial ownership stake in Iradimed Corporation.
NASDAQ
IRMD
Iradimed CORP
SCHEDULE: Nine Ten Capital Discloses 3.4% Stake in iRadimed
Nine Ten Capital Management and affiliates reported a 3.4% beneficial ownership stake in iRadimed Corp, holding 428,477 common shares.
NASDAQ
IRMD
Iradimed CORP
SCHEDULE 13G/A: BlackRock Amends Passive Stake in IRADIMED CORP, Holding 3.9% of Common Stock
BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, disclosing a passive beneficial ownership of 3.9% in IRADIMED CORP's common stock as of March 31, 2025.
NASDAQ
IRMD
Iradimed CORP
SCHEDULE 13G: Nine Ten Capital Management Discloses 7.1% Stake in iRadimed Corp
Nine Ten Capital Management, along with Nine Ten Partners LP and Russell Mollen, has disclosed a beneficial ownership of 7.1% in iRadimed Corp's common stock.